Updated from 7:00 a.m. EST

American Home Products


said Tuesday that it will sell its agricultural products unit to Germany's



for $3.8 billion in cash and the assumption of some debt.

Pharmaceuticals maker American Home announced on Feb. 7 that it would sell its

Cyanamid Agricultural Products

division by the end of the year in order to concentrate on its pharmaceutical and health care businesses. The farm products division develops and markets herbicides, insecticides and fungicides.

Analysts calculate the debt portion at $100 million.

The deal occurred more quickly and for more money than expected, with an expected price of $3 billion.


Cyanamid has been a difficult business for them

AHP and people who invest in pharmaceuticals generally don't like the ag business because it's cyclical," said analyst Kent Blair of

Donaldson Lufkin & Jenrette

. "This enhances the attractiveness of the company significantly." He rates American Home a buy and his firm has done no underwriting for the company.

The divestiture makes American Home a more attractive

merger candidate, though it must still settle the matter of its diet drug liability problems. A potential merger with



fell through six weeks ago, while similar deals with


(MTC) - Get Report


SmithKline Beecham

(SBH) - Get Report

also collapsed in the past two years.

"With the resolution of the diet pill situation in a couple months, things are really playing out for them," Blair added.

Today's purchase catapults BASF, based in Ludwigshafen, Germany, into the top three agrochemical producers worldwide, from its current rank of No. 9, and greatly strengthens its position in the U.S. market.

Its crop protection sales will more than double, from $1.9 billion in 1999, but its 13% market share will still trail Syngenta, the industry leader formed by the pending spinoffs of





(AZN) - Get Report


BASF is buying the division at the bottom of the cycle for the agricultural products business, which has been hit by increased competition as well as considerable criticism for the development of genetically modified foods. In particular, Cyanamid's soya bean herbicide is competing with Monsanto's biotechnology-enhanced Roundup product. However, the backlash against genetically modified foods may help Cyanamid in the short term.

BASF also said the acquisition will make a positive contribution to earnings starting in 2001, with $250 million in cost savings expected.

Over the last four years, BASF has sought to strengthen its crop protection portfolio with the acquisition of


North American corn herbicide business in 1996, a majority stake in generic product supplier

Micro Flo

in 1998 and a 40% stake in European seed supplier

Svalof Weibull

in 1999.

The transaction is expected to be completed by July 1.

Other bidders for the unit included




Dow Chemical

(DOW) - Get Report


Sumitomo Chemical


Shares of American Home, based in Madison, N.J., closed Monday trading at 52 7/16, up 1 3/16, or 2%. BASF's American depositary receipts closed at 47 7/8, down 1, or 2%. In midday trading on the Frankfurt bourse, BASF shares were down 0.75 euros, or 2%, to 48.75 euros. There was no action in pre-market trading, according to